Safety Evaluation Study of Pitavastatin PLGA Nano-particle for Retinitis Pigmentosa

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Safety Evaluation Study of Pitavastatin PLGA Nano-particle for Retinitis Pigmentosa	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, eye disorder, hereditary disease, inherited retinal dystrophy, retinal degeneration, retinal disorder, retinitis pigmentosa	Recruiting	Phase 1	2026-10-07		NCT07774975

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Kyushu University	6

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Kyushu University Hospital	Fukuoka	Japan	20

Clinical trials